DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | ACACA | 31 | acetyl-CoA carboxylase alpha | Q13085 |
C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | ACACA | 31 | acetyl-CoA carboxylase alpha | Q13085 |
C0007134 | Renal Cell Carcinoma | ACACA | 31 | acetyl-CoA carboxylase alpha | Q13085 |
C0037286 | Skin Neoplasms | ACACA | 31 | acetyl-CoA carboxylase alpha | Q13085 |
C0007194 | Hypertrophic Cardiomyopathy | ACACA | 31 | acetyl-CoA carboxylase alpha | Q13085 |
C1536500 | Deficiency of acetyl-CoA acetyltransferase | ACAA2 | 10449 | acetyl-CoA acyltransferase 2 | P42765 |
C0035222 | Respiratory Distress Syndrome, Adult | ACAA2 | 10449 | acetyl-CoA acyltransferase 2 | P42765 |
C0029408 | Degenerative polyarthritis | ACAA2 | 10449 | acetyl-CoA acyltransferase 2 | P42765 |
C2239176 | Liver carcinoma | ACAA2 | 10449 | acetyl-CoA acyltransferase 2 | P42765 |
C0004096 | Asthma | ACAA1 | 30 | acetyl-CoA acyltransferase 1 | P09110 |
C0577631 | Carotid Atherosclerosis | ACAA1 | 30 | acetyl-CoA acyltransferase 1 | P09110 |
C3658299 | Zellweger Spectrum | ACAA1 | 30 | acetyl-CoA acyltransferase 1 | P09110 |
C1536500 | Deficiency of acetyl-CoA acetyltransferase | ACAA1 | 30 | acetyl-CoA acyltransferase 1 | P09110 |
C0264408 | Childhood asthma | ACAA1 | 30 | acetyl-CoA acyltransferase 1 | P09110 |
C0024305 | Lymphoma, Non-Hodgkin | ACAA1 | 30 | acetyl-CoA acyltransferase 1 | P09110 |
C2239176 | Liver carcinoma | ACAA1 | 30 | acetyl-CoA acyltransferase 1 | P09110 |
C0027051 | Myocardial Infarction | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0018889 | Helminthiasis | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0020445 | Hypercholesterolemia, Familial | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0006826 | Malignant Neoplasms | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0007138 | Carcinoma, Transitional Cell | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0677886 | Epithelial ovarian cancer | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0007097 | Carcinoma | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0346647 | Malignant neoplasm of pancreas | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0010068 | Coronary heart disease | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024